Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 15, 2026
TickeronGET DAILY SIGNALS
Badger Meter (BMI) Analyst Targets Signal +13% Upside Opportunity

Badger Meter (BMI) Analyst Targets Signal +13% Upside Opportunity

Key Takeaways

  • The central price target of $175 is the average of the six verified analyst price targets that sit above the current price; it implies roughly 13% upside.
  • Badger Meter, Inc. (BMI) recently closed near $154.72, in the middle of its 52-week range of about $112 to $187.
  • The overall mean of all eight verified targets reviewed is about $163, across a wide range from $112 (Barclays) to $187 (RBC Capital).
  • Bullish analysts emphasize margin expansion, smart-water and AMI demand, and a rising dividend; the main bear case is a premium valuation with near-flat revenue.
  • Reaching $175 would require the stock to move back toward its prior 52-week high and clear a $168–$175 resistance zone.
  • For more detail, explore Major News, Today's Price Move, Forecast, and Earnings.
  • Explore Trending AI Robots to see how AI-driven tools are scanning the market for opportunities.

Analyst Price Targets and Consensus View

Badger Meter is a stock, not an ETF, and it carries broad but divided sell-side coverage. Eight verified, current price targets were reviewed, spanning roughly $112 to $187. The arithmetic mean of all eight is about $163 — only about 5% above the latest close, which does not represent a meaningful hurdle. Accordingly, the central target used here is the average of the six targets that sit above the current price: RBC Capital ($187), Seaport Global ($175), Baird ($175), Argus Research ($170), J.P. Morgan ($170), and Stifel ($168). That average is roughly $174, rounded to $175. In my view, this focused average gives a clearer sense of where upside potential lies.

Views diverge sharply. The bulls — RBC, Seaport, Baird, Argus, J.P. Morgan, and Stifel — generally cite margin expansion, software and AMI (advanced metering infrastructure) growth, and strong cash generation. Barclays is the notable dissenter, holding an Underweight rating with a $112 target on valuation concerns, while Northcoast's $148 target sits below the current price. Most recent actions were post-earnings target increases, including RBC raising to $187 from $162 and Argus upgrading to Buy. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position and Path Toward the Target

Shares recently closed near $154.72. Reaching $175 would require a gain of roughly 13%, a substantial but not extreme move for a high-multiple industrial-technology name. The company reported third-quarter EPS of $1.24, up about 4% year over year and ahead of estimates, with an operating margin near 20.2%, even though revenue of roughly $235.9 million was essentially flat. Full-year revenue is expected to be roughly flat to slightly lower versus 2025, so the near-term story rests on margins, pricing, and mix rather than rapid top-line growth.

What Could Support a Move Toward the Target

  • Sustained operating-margin expansion and cost discipline, with margins near 20%.
  • Long-term water-infrastructure modernization and smart-meter/AMI adoption tailwinds.
  • Growing recurring software and data revenue layered on hardware sales.
  • A dividend increase and healthy free cash flow supporting shareholder returns.
  • Recent analyst target increases and the Argus upgrade to Buy.

What Could Prevent the Target From Being Reached

  • A premium valuation — roughly a forward P/E of about 36 — that leaves little room for error.
  • Near-flat revenue and any slowdown in utility capital spending or project timing.
  • Competition in flow-measurement and connectivity markets.
  • Valuation compression of the kind Barclays' well-below-market target anticipates.
  • Sensitivity of high-multiple industrial names to interest rates and broader risk appetite.

Technical Levels and Market Structure

The stock trades below its 52-week high near $187, which is the key resistance zone and coincides with the highest analyst target. Support sits near $150 and again in the $140s. A sustained move toward $175 would require clearing the $168–$175 area just beneath the prior peak, making that region the critical technical test. From what I see, monitoring these levels closely helps frame realistic expectations.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms differ. Investors should watch quarterly results and forward guidance, gross and operating margin trends, AMI and software adoption, dividend news, analyst revisions, and interest-rate moves that influence high-multiple stocks.

AI Daily Buy/Sell Signals

I rely on AI Daily Buy/Sell Signals as part of my routine to track stocks like BMI. These tools apply artificial intelligence to scan thousands of names in real time, surfacing Buy, Sell, or Hold signals based on price action, momentum, and volume shifts. For a name where sentiment can change quickly around earnings and valuation debates, they help highlight potential turning points and keep an eye on existing positions without sifting through noise manually.

Final Assessment

The $175 central target reflects the average of six analyst targets above the current price, not a guarantee. It requires a move of about 13% from roughly $154.72, back toward the stock's prior 52-week high. Support comes from margin momentum, smart-water demand, and recent analyst upgrades, while the principal obstacles are a rich valuation, near-flat revenue, and one prominent bearish target well below the stock. With targets ranging from $112 to $187, the disagreement is wide, and the outcome will likely hinge on whether margin and AMI momentum can offset a premium multiple. No definitive forecast is warranted; investors should weigh the evidence and monitor earnings and analyst revisions closely.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BMI

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


BMI in upward trend: 10-day moving average moved above 50-day moving average on October 22, 2026

The 10-day moving average for BMI crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on BMI as a result. In 55 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.

BMI moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in 184 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.

The Aroon Indicator entered an Uptrend today. In 110 of 211 cases where BMI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.

Bearish Trend Analysis

The 10-day RSI Indicator for BMI moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 15 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 63 cases where BMI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 63%.

The Moving Average Convergence Divergence Histogram (MACD) for BMI turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 23 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 49%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

BMI broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. BMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.

The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.714) is normal, around the industry mean (1.448). P/E Ratio (36.786) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (2.931) is also within normal values, averaging (5.470). Dividend Yield (0.011) settles around the average of (0.012) among similar stocks. P/S Ratio (4.255) is also within normal values, averaging (32.028).

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 7.99B. The market cap for tickers in the group ranges from 12.56K to 120.89B. KYCCF holds the highest valuation in this group at 120.89B. The lowest valued company is FLXT at 12.56K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was 5%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -13%. FCUV experienced the highest price growth at 130%, while ARAI experienced the biggest fall at -51%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was 87%. For the same stocks of the Industry, the average monthly volume growth was 232% and the average quarterly volume growth was 107%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 50
Price Growth Rating: 61
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: 6 (-100 ... +100)
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a maker of flow measurement and control products

Industry ElectronicEquipmentInstruments

Industry
Electronic Equipment Or Instruments
Address
4545 West Brown Deer Road
Phone
+1 414 355-0400
Employees
2477
Web
https://www.badgermeter.com
Interact to see
Advertisement
NVIDIA shares declined roughly 26% over the 30 days ending mid-November, falling from a close near $221 to $162.85. The drop left the stock about 30% below its October 6 record intraday high of $243.37 and at a 52-week low.
ACHR fell -7.44% in Monday's regular session, sliding from Friday's $4.03 close to $3.73 shortly after 10 a.m. ET — a third consecutive daily decline that pushed shares back toward their November 5 low. No verified news or fundamental catalyst found for today's leg lower; the selling extends the de-rating that followed Q3 results — revenue of just $5.1 million, a net loss widening 111% to $274.6 million, and price-target cuts from Cantor Fitzgerald, Needham and Canaccord.
Micron shares fell -6.28% to $729.40 from Friday's $778.31 close, gapping lower in premarket trading and holding those losses into Monday's regular session. The decline was sector-driven, not company-specific: memory peers SanDisk, SK hynix and Western Digital slid in tandem as last week's Nvidia CEO departure revived doubts over AI data-center spending, financing and memory demand durability.
Dell Technologies (DELL) fell roughly 23.7% over the last 30 days, sliding from a closing price of $451.71 on October 16, 2026, to $344.53 on November 13, 2026. The decline accelerated after the U.S. midterm elections, when investor concerns about potential AI and data-center regulation triggered a sharp sell-off across AI hardware names.
LITE is the Nasdaq-listed ticker for Lumentum Holdings Inc., a global manufacturer of optical and photonic products used in data centers, AI infrastructure, and telecommunications networks. The company was spun off from JDS Uniphase and incorporated in 2015, with headquarters in San Jose, California.